全球经肠营养市场规模、份额、趋势和成长分析报告（2026-2034年）

经肠营养市场预计将从 2025 年的 73 亿美元成长到 2034 年的 125.2 亿美元，2026 年至 2034 年的复合年增长率为 6.17%。

由于吞嚥障碍和营养不良患者对营养支持的需求不断增长，经肠营养市场正经历显着增长。经肠营养专为那些难以经口摄取营养的人而设计，例如慢性病患者、神经系统疾病患者以及术后復健患者。癌症、中风和胃肠道疾病等疾病发生率的上升也推动了对经肠营养解决方案的需求。随着医疗保健机构努力确保患者获得适当的营养，经肠营养市场预计将持续扩张。

技术创新在塑造经肠营养市场的未来方面发挥关键作用。配方科学的创新，例如针对特定疾病的专用配方的开发，正在提高经肠营养的有效性。此外，包装和输送系统的进步，包括即用型和便携式产品，正在提升经肠营养产品的便利性和可及性。随着製造商持续加大研发投入，预计经肠营养市场将在包括医院、长期照护机构和居家医疗在内的各种医疗机构中得到更广泛的应用。

此外，以患者为中心的护理和个人化营养管理日益受到重视，这正推动经肠营养市场的发展。随着患者及其看护者对自身营养需求的了解不断加深，对能够满足个体偏好和饮食限制的经肠营养的需求也日益增长。这一趋势促使製造商、医疗保健机构和营养师携手合作，共同开发客製化解决方案，以提高患者满意度和营养计划的依从性。随着市场的不断发展，技术应用、个人化服务以及患者参与度的提升将是未来成功的关键。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球经肠营养市场（依产品类型划分）

• 市场分析、洞察与预测
• 标准配方
• 疾病特异性配方
• 混合配方

第五章 全球经肠营养市场分阶段分析

• 市场分析、洞察与预测
• 成人
• 儿童

6. 全球经肠营养市场（依形式划分）

• 市场分析、洞察与预测
• 液体
• 粉末

7. 全球经肠营养市场（依最终用户划分）

• 市场分析、洞察与预测
• 医院
• 居家照护
• 长期照护机构

8. 全球经肠营养市场（依通路划分）

• 市场分析、洞察与预测
• 医院药房
• 零售药房
• 网路药房

9. 全球经肠营养市场（依地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第十一章 公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • NestlAfA（C）Health Science
  • Danone SA
  • Fresenius Kabi AG
  • Mead Johnson Nutrition Company
  • Meiji Holdings Co. Ltd
  • B. Braun Melsungen AG
  • Hormel Foods Corporation
  • Victus Inc
  • Nutritional Medicinals LLC
  • Kate Farms
  • Nutricia Advanced Medical Nutrition
  • Medline Industries Inc
  • Vitasoy International Holdings Limited
  • Nutritional Resources Inc

The Enteral Feeding Formulas Market size is expected to reach USD 12.52 Billion in 2034 from USD 7.30 Billion (2025) growing at a CAGR of 6.17% during 2026-2034.

The Enteral Feeding Formulas Market is experiencing significant growth as the demand for nutritional support for patients with swallowing difficulties or malnutrition increases. Enteral feeding formulas are specially designed to provide essential nutrients to individuals who cannot consume food orally, including those with chronic illnesses, neurological disorders, and post-surgical recovery. The rising prevalence of conditions such as cancer, stroke, and gastrointestinal disorders is driving the demand for enteral feeding solutions. As healthcare providers seek to ensure adequate nutrition for patients, the market for enteral feeding formulas is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the enteral feeding formulas market. Innovations in formulation science, such as the development of specialized formulas tailored to specific medical conditions, are enhancing the effectiveness of enteral nutrition. Additionally, advancements in packaging and delivery systems, including ready-to-use and portable options, are improving the convenience and accessibility of enteral feeding products. As manufacturers continue to invest in research and development, the enteral feeding formulas market is likely to see increased adoption across various healthcare settings, including hospitals, long-term care facilities, and home healthcare.

Moreover, the growing emphasis on patient-centered care and personalized nutrition is influencing the enteral feeding formulas market's growth trajectory. As patients and caregivers become more informed about nutritional needs, there is a rising demand for enteral formulas that cater to individual preferences and dietary restrictions. This trend is driving collaboration between manufacturers, healthcare providers, and nutritionists to develop customized solutions that enhance patient satisfaction and adherence to feeding regimens. As the market continues to evolve, the integration of technology, personalization, and patient engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Standard Formulas
• Disease-Specific Formulas
• Blenderized Formulas

By Stage

• Adult
• Pediatric

By Form

• Liquid
• Powder

By End-User

• Hospitals
• Home Care
• Long-Term Care Facilities

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Abbott Laboratories, Nestl Health Science, Danone SA, Fresenius Kabi AG, Mead Johnson Nutrition Company, Meiji Holdings Co Ltd, B Braun Melsungen AG, Hormel Foods Corporation, Victus Inc, Nutritional Medicinals LLC, Kate Farms, Nutricia Advanced Medical Nutrition, Medline Industries Inc, Vitasoy International Holdings Limited, Nutritional Resources Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Standard Formulas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Disease-Specific Formulas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Blenderized Formulas Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY STAGE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Stage
• 5.2. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY FORM 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Form
• 6.2. Liquid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Powder Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Home Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Long-Term Care Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Distribution Channel
• 8.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL ENTERAL FEEDING FORMULAS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product Type
  • 9.2.2 By Stage
  • 9.2.3 By Form
  • 9.2.4 By End-user
  • 9.2.5 By Distribution Channel
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product Type
  • 9.3.2 By Stage
  • 9.3.3 By Form
  • 9.3.4 By End-user
  • 9.3.5 By Distribution Channel
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product Type
  • 9.4.2 By Stage
  • 9.4.3 By Form
  • 9.4.4 By End-user
  • 9.4.5 By Distribution Channel
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product Type
  • 9.5.2 By Stage
  • 9.5.3 By Form
  • 9.5.4 By End-user
  • 9.5.5 By Distribution Channel
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product Type
  • 9.6.2 By Stage
  • 9.6.3 By Form
  • 9.6.4 By End-user
  • 9.6.5 By Distribution Channel
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL ENTERAL FEEDING FORMULAS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 NestlAfA(C) Health Science
  • 11.2.3 Danone S.A
  • 11.2.4 Fresenius Kabi AG
  • 11.2.5 Mead Johnson Nutrition Company
  • 11.2.6 Meiji Holdings Co. Ltd
  • 11.2.7 B. Braun Melsungen AG
  • 11.2.8 Hormel Foods Corporation
  • 11.2.9 Victus Inc
  • 11.2.10 Nutritional Medicinals LLC
  • 11.2.11 Kate Farms
  • 11.2.12 Nutricia Advanced Medical Nutrition
  • 11.2.13 Medline Industries Inc
  • 11.2.14 Vitasoy International Holdings Limited
  • 11.2.15 Nutritional Resources Inc